世界の泌尿器薬市場 2019年

【英語タイトル】Global Urinary Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料(DATA909X17159)・商品コード:DATA909X17159
・発行会社(調査会社):QYResearch
・発行日:2019年11月22日(※2024年版があります。お問い合わせください)
・ページ数:107
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、泌尿器薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口剤、注射剤に、用途別には、病院、クリニック、ホームケアにセグメント区分し、泌尿器薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・泌尿器薬の世界市場概要
・泌尿器薬の製造コスト構成分析
・泌尿器薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・泌尿器薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・泌尿器薬のセグメント分析(種類別)
(経口剤、注射剤)
・泌尿器薬のセグメント分析(用途別)
(病院、クリニック、ホームケア)
・泌尿器薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Sanofi S.A.、Astellas Pharma Inc.、Daiichi Sankyo Company Limited、Pfizer Inc.、Bayer AG、Allergan Plc.、Otsuka Pharmaceutical Co., Ltd.、GlaxosmithKline Plc.、)
・泌尿器薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Urinary Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Urinary Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Urinary Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Urinary Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Urinary Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sanofi S.A.
Astellas Pharma Inc.
Daiichi Sankyo Company Limited
Pfizer Inc.
Bayer AG
Allergan Plc.
Otsuka Pharmaceutical Co., Ltd.
GlaxosmithKline Plc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral
Injectables

Segment by Application
Hospital
Clinic
Home Care

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Urinary Drugs
1.1 Definition of Urinary Drugs
1.2 Urinary Drugs Segment by Type
1.2.1 Global Urinary Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral
1.2.3 Injectables
1.3 Urinary Drugs Segment by Applications
1.3.1 Global Urinary Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Urinary Drugs Overall Market
1.4.1 Global Urinary Drugs Revenue (2014-2025)
1.4.2 Global Urinary Drugs Production (2014-2025)
1.4.3 North America Urinary Drugs Status and Prospect (2014-2025)
1.4.4 Europe Urinary Drugs Status and Prospect (2014-2025)
1.4.5 China Urinary Drugs Status and Prospect (2014-2025)
1.4.6 Japan Urinary Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Urinary Drugs Status and Prospect (2014-2025)
1.4.8 India Urinary Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Urinary Drugs
2.3 Manufacturing Process Analysis of Urinary Drugs
2.4 Industry Chain Structure of Urinary Drugs

3 Development and Manufacturing Plants Analysis of Urinary Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Urinary Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Urinary Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Urinary Drugs Production and Capacity Analysis
4.2 Urinary Drugs Revenue Analysis
4.3 Urinary Drugs Price Analysis
4.4 Market Concentration Degree

5 Urinary Drugs Regional Market Analysis
5.1 Urinary Drugs Production by Regions
5.1.1 Global Urinary Drugs Production by Regions
5.1.2 Global Urinary Drugs Revenue by Regions
5.2 Urinary Drugs Consumption by Regions
5.3 North America Urinary Drugs Market Analysis
5.3.1 North America Urinary Drugs Production
5.3.2 North America Urinary Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Urinary Drugs Import and Export
5.4 Europe Urinary Drugs Market Analysis
5.4.1 Europe Urinary Drugs Production
5.4.2 Europe Urinary Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Urinary Drugs Import and Export
5.5 China Urinary Drugs Market Analysis
5.5.1 China Urinary Drugs Production
5.5.2 China Urinary Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Urinary Drugs Import and Export
5.6 Japan Urinary Drugs Market Analysis
5.6.1 Japan Urinary Drugs Production
5.6.2 Japan Urinary Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Urinary Drugs Import and Export
5.7 Southeast Asia Urinary Drugs Market Analysis
5.7.1 Southeast Asia Urinary Drugs Production
5.7.2 Southeast Asia Urinary Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Urinary Drugs Import and Export
5.8 India Urinary Drugs Market Analysis
5.8.1 India Urinary Drugs Production
5.8.2 India Urinary Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Urinary Drugs Import and Export

6 Urinary Drugs Segment Market Analysis (by Type)
6.1 Global Urinary Drugs Production by Type
6.2 Global Urinary Drugs Revenue by Type
6.3 Urinary Drugs Price by Type

7 Urinary Drugs Segment Market Analysis (by Application)
7.1 Global Urinary Drugs Consumption by Application
7.2 Global Urinary Drugs Consumption Market Share by Application (2014-2019)

8 Urinary Drugs Major Manufacturers Analysis
8.1 Sanofi S.A.
8.1.1 Sanofi S.A. Urinary Drugs Production Sites and Area Served
8.1.2 Sanofi S.A. Product Introduction, Application and Specification
8.1.3 Sanofi S.A. Urinary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Astellas Pharma Inc.
8.2.1 Astellas Pharma Inc. Urinary Drugs Production Sites and Area Served
8.2.2 Astellas Pharma Inc. Product Introduction, Application and Specification
8.2.3 Astellas Pharma Inc. Urinary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Daiichi Sankyo Company Limited
8.3.1 Daiichi Sankyo Company Limited Urinary Drugs Production Sites and Area Served
8.3.2 Daiichi Sankyo Company Limited Product Introduction, Application and Specification
8.3.3 Daiichi Sankyo Company Limited Urinary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer Inc.
8.4.1 Pfizer Inc. Urinary Drugs Production Sites and Area Served
8.4.2 Pfizer Inc. Product Introduction, Application and Specification
8.4.3 Pfizer Inc. Urinary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bayer AG
8.5.1 Bayer AG Urinary Drugs Production Sites and Area Served
8.5.2 Bayer AG Product Introduction, Application and Specification
8.5.3 Bayer AG Urinary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Allergan Plc.
8.6.1 Allergan Plc. Urinary Drugs Production Sites and Area Served
8.6.2 Allergan Plc. Product Introduction, Application and Specification
8.6.3 Allergan Plc. Urinary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Otsuka Pharmaceutical Co., Ltd.
8.7.1 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Production Sites and Area Served
8.7.2 Otsuka Pharmaceutical Co., Ltd. Product Introduction, Application and Specification
8.7.3 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 GlaxosmithKline Plc.
8.8.1 GlaxosmithKline Plc. Urinary Drugs Production Sites and Area Served
8.8.2 GlaxosmithKline Plc. Product Introduction, Application and Specification
8.8.3 GlaxosmithKline Plc. Urinary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Urinary Drugs Market
9.1 Global Urinary Drugs Market Trend Analysis
9.1.1 Global Urinary Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Urinary Drugs Regional Market Trend
9.2.1 North America Urinary Drugs Forecast 2019-2025
9.2.2 Europe Urinary Drugs Forecast 2019-2025
9.2.3 China Urinary Drugs Forecast 2019-2025
9.2.4 Japan Urinary Drugs Forecast 2019-2025
9.2.5 Southeast Asia Urinary Drugs Forecast 2019-2025
9.2.6 India Urinary Drugs Forecast 2019-2025
9.3 Urinary Drugs Market Trend (Product Type)
9.4 Urinary Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Urinary Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Urinary Drugs
Table Global Urinary Drugs Production (MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Urinary Drugs Production Market Share by Types in 2018
Figure Oral Product Picture
Figure Injectables Product Picture
Table Global Urinary Drugs Consumption (MT) Comparison by Applications (2014-2025)
Figure Global Urinary Drugs Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Home Care
Figure Global Urinary Drugs Revenue (Million USD) (2014-2025)
Figure Global Urinary Drugs Production (MT) (2014-2025)
Figure North America Urinary Drugs Market Size (Million USD) (2014-2025)
Figure Europe Urinary Drugs Market Size (Million USD) (2014-2025)
Figure China Urinary Drugs Market Size (Million USD) (2014-2025)
Figure Japan Urinary Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Urinary Drugs Market Size (Million USD) (2014-2025)
Figure India Urinary Drugs Market Size (Million USD) (2014-2025)
Table Urinary Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Urinary Drugs in 2018
Figure Manufacturing Process Analysis of Urinary Drugs
Figure Industry Chain Structure of Urinary Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Urinary Drugs Manufacturing Plants Distribution
Table Urinary Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Urinary Drugs Capacity (MT) of Major Manufacturers (2014-2019)
Table Urinary Drugs Production (MT) of Major Manufacturers (2014-2019)
Table Urinary Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Urinary Drugs Production Share by Manufacturers in 2018
Table Urinary Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Urinary Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Urinary Drugs Revenue Share by Manufacturers in 2018
Table Urinary Drugs Average Price (USD/Kg) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Urinary Drugs Production by Regions 2014-2019 (MT)
Table Global Urinary Drugs Production Market Share by Regions 2014-2019
Figure Global Urinary Drugs Production Market Share by Regions in 2018
Table Global Urinary Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Urinary Drugs Revenue Market Share by Regions 2014-2019
Figure Global Urinary Drugs Revenue Market Share by Regions in 2018
Table Global Urinary Drugs Consumption by Regions 2014-2019 (MT)
Table Global Urinary Drugs Consumption Market Share by Regions 2014-2019
Figure North America Urinary Drugs Production Growth Rate 2014-2019 (MT)
Figure North America Urinary Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Urinary Drugs Production, Consumption Import and Export (MT)
Figure Europe Urinary Drugs Production Growth Rate 2014-2019 (MT)
Figure Europe Urinary Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Urinary Drugs Production, Consumption Import and Export (MT)
Figure China Urinary Drugs Production Growth Rate 2014-2019 (MT)
Figure China Urinary Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Urinary Drugs Production, Consumption Import and Export (MT)
Figure Japan Urinary Drugs Production Growth Rate 2014-2019 (MT)
Figure Japan Urinary Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Urinary Drugs Production, Consumption Import and Export (MT)
Figure Southeast Asia Urinary Drugs Production Growth Rate 2014-2019 (MT)
Figure Southeast Asia Urinary Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Urinary Drugs Production, Consumption Import and Export (MT)
Figure India Urinary Drugs Production Growth Rate 2014-2019 (MT)
Figure India Urinary Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Urinary Drugs Production, Consumption Import and Export (MT)
Figure Global Consumption Urinary Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Urinary Drugs Market Share by Application (2014-2019)
Table Sanofi S.A. Urinary Drugs Production Sites and Area Served
Table Sanofi S.A. Urinary Drugs Product Introduction, Application and Specification
Table Sanofi S.A. Urinary Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Sanofi S.A. Urinary Drugs Production Growth Rate (2014-2019)
Table Sanofi S.A. Urinary Drugs Production Market Share (2014-2019)
Figure Sanofi S.A. Urinary Drugs Revenue Market Share (2014-2019)
Table Sanofi S.A. Urinary Drugs Main Business and Markets Served
Table Astellas Pharma Inc. Urinary Drugs Production Sites and Area Served
Table Astellas Pharma Inc. Urinary Drugs Product Introduction, Application and Specification
Table Astellas Pharma Inc. Urinary Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Astellas Pharma Inc. Urinary Drugs Production Growth Rate (2014-2019)
Table Astellas Pharma Inc. Urinary Drugs Production Market Share (2014-2019)
Figure Astellas Pharma Inc. Urinary Drugs Revenue Market Share (2014-2019)
Table Astellas Pharma Inc. Urinary Drugs Main Business and Markets Served
Table Daiichi Sankyo Company Limited Urinary Drugs Production Sites and Area Served
Table Daiichi Sankyo Company Limited Urinary Drugs Product Introduction, Application and Specification
Table Daiichi Sankyo Company Limited Urinary Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Daiichi Sankyo Company Limited Urinary Drugs Production Growth Rate (2014-2019)
Table Daiichi Sankyo Company Limited Urinary Drugs Production Market Share (2014-2019)
Figure Daiichi Sankyo Company Limited Urinary Drugs Revenue Market Share (2014-2019)
Table Daiichi Sankyo Company Limited Urinary Drugs Main Business and Markets Served
Table Pfizer Inc. Urinary Drugs Production Sites and Area Served
Table Pfizer Inc. Urinary Drugs Product Introduction, Application and Specification
Table Pfizer Inc. Urinary Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer Inc. Urinary Drugs Production Growth Rate (2014-2019)
Table Pfizer Inc. Urinary Drugs Production Market Share (2014-2019)
Figure Pfizer Inc. Urinary Drugs Revenue Market Share (2014-2019)
Table Pfizer Inc. Urinary Drugs Main Business and Markets Served
Table Bayer AG Urinary Drugs Production Sites and Area Served
Table Bayer AG Urinary Drugs Product Introduction, Application and Specification
Table Bayer AG Urinary Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Bayer AG Urinary Drugs Production Growth Rate (2014-2019)
Table Bayer AG Urinary Drugs Production Market Share (2014-2019)
Figure Bayer AG Urinary Drugs Revenue Market Share (2014-2019)
Table Bayer AG Urinary Drugs Main Business and Markets Served
Table Allergan Plc. Urinary Drugs Production Sites and Area Served
Table Allergan Plc. Urinary Drugs Product Introduction, Application and Specification
Table Allergan Plc. Urinary Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Allergan Plc. Urinary Drugs Production Growth Rate (2014-2019)
Table Allergan Plc. Urinary Drugs Production Market Share (2014-2019)
Figure Allergan Plc. Urinary Drugs Revenue Market Share (2014-2019)
Table Allergan Plc. Urinary Drugs Main Business and Markets Served
Table Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Production Sites and Area Served
Table Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Product Introduction, Application and Specification
Table Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Production Growth Rate (2014-2019)
Table Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Production Market Share (2014-2019)
Figure Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Revenue Market Share (2014-2019)
Table Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Main Business and Markets Served
Table GlaxosmithKline Plc. Urinary Drugs Production Sites and Area Served
Table GlaxosmithKline Plc. Urinary Drugs Product Introduction, Application and Specification
Table GlaxosmithKline Plc. Urinary Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table GlaxosmithKline Plc. Urinary Drugs Production Growth Rate (2014-2019)
Table GlaxosmithKline Plc. Urinary Drugs Production Market Share (2014-2019)
Figure GlaxosmithKline Plc. Urinary Drugs Revenue Market Share (2014-2019)
Table GlaxosmithKline Plc. Urinary Drugs Main Business and Markets Served
Figure Global Urinary Drugs Production (MT) Growth Rate Forecast 2019-2025
Figure Global Urinary Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Urinary Drugs Sales Price (USD/Kg) Forecast 2019-2025
Figure North America Urinary Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure North America Urinary Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Urinary Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure Europe Urinary Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Urinary Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure China Urinary Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Urinary Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure Japan Urinary Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Urinary Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure Southeast Asia Urinary Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Urinary Drugs Production Growth Rate Forecast 2019-2025 (MT)
Figure India Urinary Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (MT) of Urinary Drugs by Type (2019-2025)
Table Global Consumption (MT) of Urinary Drugs by Application (2019-2025)
Table Urinary Drugs Distributors List
Table Urinary Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Sanofi S.A.、Astellas Pharma Inc.、Daiichi Sankyo Company Limited、Pfizer Inc.、Bayer AG、Allergan Plc.、Otsuka Pharmaceutical Co., Ltd.、GlaxosmithKline Plc.、

★調査レポート[世界の泌尿器薬市場 2019年] (コード:DATA909X17159)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の泌尿器薬市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆